2021年WHO中枢神经系统肿瘤分类:面向神经放射科医生的综述
该综述总结2021年第五版WHO中枢神经系统肿瘤分类(WHO CNS5)对神经放射科医生最相关的更新,包括引入新的肿瘤家族与类型(尤其儿童人群)及修订部分现有肿瘤的诊断标准;WHO CNS5更强调按分子类型组织肿瘤以反映生物学行为并利于治疗规划,成人肿瘤主要更新涉及胶质母细胞瘤的分子定义、弥漫性胶质瘤的重组及若干新肿瘤类型的引入,儿童分类更新广泛。
要点
- WHO CNS5强调按分子类型组织中枢神经系统肿瘤以反映生物学行为并利于治疗规划。
- 成人肿瘤主要更新包括胶质母细胞瘤的分子定义、弥漫性胶质瘤的重组及若干新肿瘤类型的引入。
- 儿童分类更新广泛,包括引入新类型及为儿童型胶质瘤设立独立的肿瘤家族。
核心结论
- WHO CNS5通过引入新的肿瘤家族和类型(尤其儿童人群)及修订部分现有肿瘤的诊断标准,对脑肿瘤分类做出根本性改变。
- WHO CNS5更强调按分子类型组织肿瘤以反映生物学行为并利于更好地规划治疗。
- 神经放射科医生处于脑肿瘤诊断的核心位置,因此必须熟悉关键更新。
研究设计与样本
- 综述,旨在总结对神经放射科医生最相关的更新,并在有资料时讨论各种新肿瘤类型的已知影像表型以提高术语和诊断准确性。
- 基于2021年出版的第五版WHO中枢神经系统肿瘤分类(WHO CNS5),该版在2016年版基础上纳入中枢神经系统肿瘤分类分子和实用方法信息联盟(cIMPACT-NOW)的输出。
诊断标准与关键数值
- 成人肿瘤主要更新涉及胶质母细胞瘤的分子定义、弥漫性胶质瘤的重组及若干新肿瘤类型的引入。
- 儿童分类更新广泛,从引入新类型到为儿童型胶质瘤设立独立的肿瘤家族。
临床应用与阅片要点
- 神经放射科医生处于脑肿瘤诊断的核心位置,必须熟悉WHO CNS5的关键更新。
- 综述在有资料时讨论各种新肿瘤类型的已知影像表型,以提高术语和诊断准确性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The fifth edition of the World Health Organization Classification of Tumours of the Central Nervous System (WHO CNS5) published in 2021 builds on the 2016 edition and incorporates output from the Consortium to Inform Molecular and Practical Approaches to CNS Tumour Taxonomy (cIMPACT-NOW). WHO CNS5 introduces fundamental changes to brain tumour classification through the introduction of new tumour families and types, especially in the paediatric population, and a revision of diagnostic criteria for some of the existing neoplasms. Neuroradiologists are central to brain tumour diagnostics, and it is therefore essential that they become familiar with the key updates. This review aims to summarise the most relevant updates for the neuroradiologist and, where available, discuss the known radiophenotypes of various new tumour types to allow for increased accuracy of language and diagnosis. Of particular importance, WHO CNS5 places greater emphasis on organising tumours by molecular type to reflect biology, as well as to allow for better planning of treatment. The principal updates in adult tumours concern the molecular definition of glioblastoma, restructuring of diffuse gliomas, and the introduction of several new tumour types. The updates to the paediatric classification are protean, ranging from the introduction of new types to establishing separate tumour families for paediatric-type gliomas. This review summarises the most significant revisions and captures the rationale and radiological implications for the major updates.
引用
- McNamara, Mankad, Thust, et al. 2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist. Neuroradiology. 2022. PMID: 35869291. doi:10.1007/s00234-022-03008-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。